These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 77190)

  • 21. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny N; Lynch G; Wookcock T
    Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluorinated Pyrimidine nucleosides. 1. Synthesis of a nitrogen analogue of the antitumor agent 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine hydrochloride.
    Cook AF
    J Med Chem; 1977 Mar; 20(3):344-8. PubMed ID: 66315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Harper HD; Kemeny NE; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
    Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group.
    Alberto P; Rozencweig M; Gangji D; Brugarolas A; Cavalli F; Siegenthaler P; Hansen HH; Sylvester R
    Eur J Cancer (1965); 1978 Feb; 14(2):195-201. PubMed ID: 75105
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
    Carroll DS; Gralla RJ; Kemeny NE
    Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
    Budman DR; Schulman P; Vinciguerra V; Degnan T
    Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
    O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
    Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
    Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Currie V
    Cancer Treat Rep; 1981; 65(1-2):127-8. PubMed ID: 7226162
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study on oral N-methylformamide in metastatic colorectal cancer.
    Planting AS; Klijn JG; Verweij J; Stoter G
    Cancer Treat Rep; 1987 Dec; 71(12):1293-4. PubMed ID: 3690540
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
    Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
    Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
    Meyers FJ; Lewis B; Mitchell E; William L; Hannigan JF; Gribble M; Torti FM
    Cancer Treat Rep; 1985 Jan; 69(1):143-4. PubMed ID: 3855385
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
    Lynch G; Currie V; Kemeny N
    Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Lanzotti V; Khandekar JD; Sweet D; Shaw J; Bitran J; Gordon L; Krauss S; Johnson C
    Cancer Treat Rep; 1986 Feb; 70(2):307-8. PubMed ID: 3948195
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclocytidine in breast cancer.
    O'Bryan RM; Baker L; Whitecar J; Salmon S; Vaughn C; Hoogstraten B
    Cancer Treat Rep; 1978 Mar; 62(3):455-6. PubMed ID: 77189
    [No Abstract]   [Full Text] [Related]  

  • 38. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
    Diaz-Rubio E; Martin-Jimenez M
    Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.
    Basler GA; Shapiro WR
    Cancer Treat Rep; 1976 Jul; 60(7):875-9. PubMed ID: 64295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
    Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
    Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.